Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
N Engl J Med. 2017 Dec 7;377(23):2215-2227. doi: 10.1056/NEJMoa1708538.
N Engl J Med. 2017.
PMID: 29211678
Free PMC article.
Clinical Trial.